Gain Therapeutics Inc (GANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,838 | 10,386 | 11,795 | 7,312 | 36,881 |
| Marketable Securities | N/A | N/A | 5,000 | 12,827 | N/A |
| Other current assets | 180 | 271 | 243 | 104 | 114 |
| TOTAL | $22,237 | $11,603 | $17,779 | $21,091 | $37,722 |
| Non-Current Assets | |||||
| PPE Net | 75 | 104 | 126 | 144 | 106 |
| Investments And Advances | 0 | 0 | 0 | 1,942 | 0 |
| Other Non-Current Assets | 507 | 418 | 705 | 922 | 1,157 |
| TOTAL | $582 | $521 | $831 | $3,008 | $1,263 |
| Total Assets | $22,819 | $12,124 | $18,609 | $24,099 | $38,985 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 101 | 110 | 119 | 108 | 104 |
| Accounts payable and accrued liabilities | 825 | 946 | 1,319 | 1,626 | 561 |
| Other current liabilities | 2,307 | 2,442 | 2,160 | 2,107 | 1,403 |
| TOTAL | $3,352 | $3,911 | $4,950 | $4,125 | $2,553 |
| Non-Current Liabilities | |||||
| Long Term Debt | 300 | 328 | 449 | 495 | 591 |
| Deferred Revenues | N/A | 252 | 1,122 | 55 | 267 |
| Other Non-Current Liabilities | 602 | 497 | 537 | 599 | 1,025 |
| TOTAL | $902 | $873 | $1,081 | $1,095 | $1,615 |
| Total Liabilities | $4,254 | $4,784 | $6,031 | $5,220 | $4,168 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,242 | 27,787 | 16,220 | 11,883 | 11,883 |
| Common Shares | 4 | 3 | 2 | 1 | 1 |
| Retained earnings | -81,195 | -60,784 | -38,516 | -20,926 | -7,035 |
| Other shareholders' equity | -19,384 | -20,659 | -22,020 | -17,555 | -13,981 |
| TOTAL | $18,565 | $7,340 | $12,578 | $18,880 | $34,818 |
| Total Liabilities And Equity | $22,819 | $12,124 | $18,609 | $24,099 | $38,985 |